The Global Exposome Summit promoted international research and coordination on the exposome and brought together researchers, policymakers, industry representatives, funders and other stakeholders committed to advancing human health through research and practice.

Professor Martie van Tongeren and Dr Rufus Daw represented The University of Manchester at the Summit in Sitges, Spain in April 2026.

Dr Daw, Senior Biomedical Data Scientist at the University and a member of the MRC CoRE in Exposome Immunology, presented a poster titled “The MRC CoRE in Exposome Immunology Mega-Omic Atlas: Mapping Exposome-Mediated Immune Dysregulation in Chronic Inflammatory Disease”.

The event highlighted the growing international momentum behind exposome research. Several Members of the European Parliament presented and contributed to discussions, reflecting the increasing policy interest in the field across Europe.

Speakers also outlined ongoing discussions around major investment in exposome research, including plans for a large European exposome cohort involving 10 million people.

Although the focus naturally was on European research, delegates from across the world joined the Summit to share their research activities, priorities and challenges.

Since Chris Wild first used the term “exposome” in 2005 [1], the field has developed rapidly and is now firmly established as an important scientific field of research.

[1] Wild CP Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005; 14(8):1847–1850.